LME-Guided Precision Combination Therapy in B-cell Lymphoma Patients After CD19 CAR-T Failure

Clinical trial NCT07602322 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07602322
Sponsor: Ruijin Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Large B-cell Lymphoma

Start date: 2026-05-14
Primary completion: 2028-05-14
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.